HANSOH PHARMACEUTICAL GROUP COMPANY LIMITEDHANSOH PHARMACEUTICAL GROUP COMPANY LIMITEDHANSOH PHARMACEUTICAL GROUP COMPANY LIMITED

HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪11.69 B‬EUR
‪420.10 M‬EUR
‪1.30 B‬EUR
‪1.08 B‬
Beta (1Y)
1.34

About HANSOH PHARMACEUTICAL GROUP CO LTD

CEO
Hui Juan Zhong
Headquarters
Shanghai
Employees (FY)
‪9.12 K‬
Founded
2015
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, anti-diabetic, gastrointestinal, and cardiovascular drugs. The company was founded by Hui Juan Zhong on December 2, 2015 and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 3KY is 1.98 EUR — it has decreased by 2.94% in the past 24 hours. Watch HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED stocks are traded under the ticker 3KY.
3KY stock has fallen by 7.48% compared to the previous week, the month change is a 1.02% rise, over the last year HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED has showed a 26.92% increase.
We've gathered analysts' opinions on HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED future price: according to them, 3KY price has a max estimate of 3.29 EUR and a min estimate of 1.76 EUR. Watch 3KY chart and read a more detailed HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED stock forecast: see what analysts think of HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED and suggest that you do with its stocks.
3KY reached its all-time high on Jan 27, 2021 with the price of 4.68 EUR, and its all-time low was 1.15 EUR and was reached on Aug 21, 2023. View more price dynamics on 3KY chart.
See other stocks reaching their highest and lowest prices.
3KY stock is 3.03% volatile and has beta coefficient of 1.34. Track HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED stock price on the chart and check out the list of the most volatile stocks — is HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED there?
Today HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED has the market capitalization of ‪11.67 B‬, it has increased by 4.16% over the last week.
Yes, you can track HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED financials in yearly and quarterly reports right on TradingView.
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
3KY earnings for the last quarter are 0.04 EUR per share, whereas the estimation was 0.03 EUR resulting in a 50.00% surprise. The estimated earnings for the next quarter are 0.05 EUR per share. See more details about HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED earnings.
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED revenue for the last quarter amounts to ‪713.71 M‬ EUR despite the estimated figure of ‪705.95 M‬ EUR. In the next quarter revenue is expected to reach ‪789.71 M‬ EUR.
3KY net income for the last quarter is ‪249.21 M‬ EUR, while the quarter before that showed ‪170.48 M‬ EUR of net income which accounts for 46.18% change. Track more HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED financial stats to get the full picture.
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED dividend yield was 1.35% in 2023, and payout ratio reached 34.83%. The year before the numbers were 0.67% and 19.69% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 25, 2024, the company has ‪9.12 K‬ employees. See our rating of the largest employees — is HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED EBITDA is ‪392.85 M‬ EUR, and current EBITDA margin is 30.46%. See more stats in HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED financial statements.
Like other stocks, 3KY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED stock shows the buy signal. See more of HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.